Category News

Evinova

Evinova and Bristol Myers Squibb Partner Strategically to Enhance Clinical Development Using AI

Evinova and Bristol Myers Squibb Forge Strategic Collaboration to Optimize Clinical Development with Artificial Intelligence Evinova today announced that Bristol Myers Squibb has signed an agreement to optimize clinical trials with Evinova’s AI-native clinical development platform. Under the terms of…

Read MoreEvinova and Bristol Myers Squibb Partner Strategically to Enhance Clinical Development Using AI
Johnson & Johnson

Johnson & Johnson Shares Early OMNY-AF Pilot Study Results at the 2026 AF Symposium

Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium Johnson & Johnson today announced 12-month pilot-phase data from the OMNY-AF study, evaluating the investigational OMNYPULSE Platform for the treatment of symptomatic paroxysmal atrial fibrillation…

Read MoreJohnson & Johnson Shares Early OMNY-AF Pilot Study Results at the 2026 AF Symposium
DISTALS

Rapid Medical’s DISTALS Trial Shows Strong Results, Highlighting Superior Reperfusion with TIGERTRIEVER™ 13

Rapid Medical’s DISTALS Trial Overwhelmingly Positive, Demonstrating Superior Reperfusion with TIGERTRIEVER™ 13 in Medium Vessel Stroke Rapid Medical™, a leading developer of active endovascular devices, today announced late-breaking results from the DISTALS multicenter, randomized controlled trial showing that TIGERTRIEVER™ 13 achieved superior…

Read MoreRapid Medical’s DISTALS Trial Shows Strong Results, Highlighting Superior Reperfusion with TIGERTRIEVER™ 13
Supplemental

Supplemental Screening Program Celebrates 20 Years, Urges Eligible Individuals to Join

National Supplemental Screening Program Celebrates 20 Years of Service; Eligible Individuals Encouraged to Participate The U.S. Department of Energy (DOE) National Supplemental Screening Program (NSSP), managed by ORAU, is celebrating 20 years of continued service and encourages those eligible to…

Read MoreSupplemental Screening Program Celebrates 20 Years, Urges Eligible Individuals to Join
Biotech Showcase

Biotech Showcase™ 2026 Highlighted Early-Stage Biotech Innovation During JPM Healthcare Week

Biotech Showcase™ 2026 Brought Early-Stage Biotech Innovation to the Forefront During JPM Healthcare Week As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18th year, the event continued to distinguish itself as a leading hub for early-stage biotechnology companies seeking meaningful visibility, strategic dialogue, and…

Read MoreBiotech Showcase™ 2026 Highlighted Early-Stage Biotech Innovation During JPM Healthcare Week
Magnus Medical

Magnus Medical Enrolls First Patient in DoD-Funded SAINT Postpartum Depression Study at UMass

Magnus Medical Announces First Patient Enrolled at University of Massachusetts in Pivotal DoD-Funded Multisite Study of SAINT for Postpartum Depression Magnus Medical, Inc., a pioneering therapeutic neuromodulation company advancing precision medicine in brain health, today announced enrollment of the first…

Read MoreMagnus Medical Enrolls First Patient in DoD-Funded SAINT Postpartum Depression Study at UMass
Health Canada

Health Canada Authorizes Mirum’s LIVMARLI® for PFIC-Related Cholestatic Pruritus Treatment

Mirum Pharmaceuticals Announces Health Canada Authorization of LIVMARLI® for the Treatment of Cholestatic Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC) Mirum Pharmaceuticals, Inc. a leading rare disease company, today announced that Health Canada has authorized LIVMARLI® (maralixibat) oral solution and…

Read MoreHealth Canada Authorizes Mirum’s LIVMARLI® for PFIC-Related Cholestatic Pruritus Treatment
Insulet

Insulet Introduces Omnipod® 5 and Omnipod Discover™ in the Middle East to Advance Diabetes Care

Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care Insulet Corporation the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its transformative Omnipod 5 Automated Insulin Delivery (AID) System is now…

Read MoreInsulet Introduces Omnipod® 5 and Omnipod Discover™ in the Middle East to Advance Diabetes Care
Leyden

Leyden Labs Shows Feasibility of a Novel Antibody-Based Nasal Spray for Influenza Prevention

Leyden Labs Demonstrates Feasibility of Novel Antibody-Based Nasal Spray for Flu Prevention Leyden Laboratories B.V. (the “Company” or “Leyden Labs”) today announced landmark preclinical and clinical data in Science Translational Medicine supporting the development of their antibody-based nasal sprays to prevent influenza…

Read MoreLeyden Labs Shows Feasibility of a Novel Antibody-Based Nasal Spray for Influenza Prevention